Evidence map›Paper›PMID 35648441›Full record

ArticleHuman vaccines & immunotherapeutics2022

Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.

Li Ping Wong, Haridah Alias, Yan-Li Siaw, Mustakiza Muslimin, Lee Lee Lai, Yulan Lin, Zhijian Hu

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Factors affecting hesitancy toward COVID-19 vaccine booster doses in Canada: a cross-national survey.Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. A survey on Malaysian's acceptance and perceptions towards COVID-19 booster dose.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Li Ping WongCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-0107-0532
Haridah AliasCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Yan-Li SiawDepartment of Educational Psychology & Counselling, Faculty of Education, Universiti Malaya, Kuala Lumpur, Malaysia.
Mustakiza MusliminDepartment of Medical Science & Technology, Faculty of Health Sciences, PICOMS International University College, Kuala Lumpur, Malaysia.
Lee Lee LaiDepartment of Nursing, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Yulan LinDepartment of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.ORCID 0000-0002-4208-9408
Zhijian HuDepartment of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.
Fujian Medical University · CNUniversity of Malaya · MYIMU University · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to provide evidence of hesitancy in receiving the COVID-19 booster vaccine and associated factors in the vaccinated population that have completed a primary vaccination series. An anonymous web-based survey was disseminated to Malaysian adults aged ≥18 years via social media platforms. A total of 1010 responses were collected, of which 43.0% (95%CI 39.9-46.0) declared a definite willingness to receive a COVID-19 vaccine booster, 38.2% (95%CI 35.2-44.3) reported being

Indexed as

COVID-19COVID-19 VaccinesInfluenza, HumanInfluenza VaccinesAdolescentAdultCross-Sectional StudiesHumansImmunization, SecondaryIntentionMalaysiaPatient Acceptance of Health CareVaccinationCOVID-19 VaccinesInfluenza VaccinesCOVID-19 vaccine booster acceptanceMalaysiapandemic fatigueside effectsvaccine hesitancy

Identifiers

PMID35648441
PMCPMC9481074
OpenAlexW4281711905

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.